[Intensive care of myelotoxic agranulocytosis using nonselective plasmapheresis].
Plasmapheresis had a marked therapeutic effect in 14 cancer patients with grave myelotoxic complications of antitumor therapy: 13 of these patients survived, felt better, isosensitization to drugs and blood preparations was eliminated, the efficacy of common detoxifying and blood-substituting therapy improved. The therapeutic effect of the procedure was obvious even in the patient who died: the anuretic stage of acute renal failure changed for the polyuretic one. Plasmapheresis caused the most pronounced shifts in the system of homeostasis maintenance. The activation of the organism's autocleansing was attended by positive laboratory and clinical shifts.
Andriukhin
V I
VI
Army Medical Department of Border Forces RF, Nizhnii-Novgorod.
Artemenko
A G
AG
D000380:Agranulocytosis / Q000139:chemically induced / Q000628:therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects*; D003422:Critical Care / Q000379:methods; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010956:Plasmapheresis
D000970:Antineoplastic Agents
Intensivnaia terapiia mielotoksicheskogo agranulotsitoza s pomoshchíu neselektivnogo plazmafereza.